Ameriprise Financial »

Revance Therapeutics shares owned by Ameriprise Financial

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Ameriprise Financial from 13F filings

Historical chart of Ameriprise Financial investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Ameriprise Financial

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.4M 126k 11.47
2023-06-30 $5.4M 213k 25.31
2023-03-31 $9.1M 281k 32.21
2022-12-31 $4.3M 234k 18.46
2022-09-30 $4.5M 168k 27.00
2022-06-30 $2.0M 143k 13.82
2022-03-31 $2.6M 135k 19.50
2021-12-31 $2.0M 121k 16.32
2021-09-30 $4.6M 166k 27.86
2021-06-30 $4.9M 166k 29.64
2021-03-31 $4.2M 150k 27.94
2020-12-31 $4.5M 160k 28.33
2020-09-30 $3.3M 133k 25.14
2020-06-30 $3.6M 148k 24.42
2020-03-31 $2.9M 196k 14.80
2019-12-31 $3.5M 217k 16.23
2019-09-30 $1.9M 147k 13.00
2019-06-30 $1.5M 118k 12.97
2019-03-31 $2.1M 136k 15.75
2018-12-31 $617k 31k 20.15
2018-09-30 $733k 30k 24.85
2018-06-30 $744k 27k 27.44
2018-03-31 $1.7M 56k 30.81
2017-12-31 $2.3M 65k 35.74
2017-09-30 $634k 23k 27.57
2017-06-30 $604k 23k 26.38
2017-03-31 $472k 23k 20.81
2016-12-31 $469k 23k 20.68
2016-03-31 $241k 14k 17.44
2015-12-31 $1.4M 42k 34.15
2014-12-31 $4.3M 253k 16.94
2014-09-30 $4.5M 235k 19.33
2014-06-30 $6.3M 184k 34.00
2014-03-31 $5.2M 165k 31.50